Epizyme Inc (NASDAQ:EPZM)
| 1.94 BATS BZX Real-Time Price As of 10:18am ET |  -0.13 / -6.28%Today’s Change | 1.94 Today|||52-Week Range 12.37 | -22.40% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 208.3M | 77.9M | 226.7M | 86.7M | |
| Short Term Investment Cash | 18.2M | -130.5M | 148.8M | -140.0M | ||
| Cash & Short Term Investments | 208.3M | 242.2M | 276.4M | 240.3M | ||
| Receivables | Receivables | 262.0K | 318.0K | 631.0K | 20.7M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | -- | 3.7M | 5.7M | 6.3M | |
| Other Current Assets | 4.5M | 2.5M | 3.0M | 5.2M | ||
| Current Assets | 213.1M | 248.7M | 285.8M | 272.5M | ||
| Total Assets | Property, Plant and Equipment - Gross | 8.8M | 8.7M | 9.4M | 9.9M | |
| Depreciation | -4.7M | -5.5M | -6.8M | -7.8M | ||
| Other Assets | 751.0K | 645.0K | 1.0M | 447.0K | ||
| Total Assets | 217.9M | 252.4M | 289.4M | 275.5M | ||
| Liabilities | Accounts Payable | 4.7M | 5.0M | 7.0M | 4.8M | |
| Short Term Debt | 561.0K | 620.0K | 110.0K | 16.0K | ||
| Accrued Expenses | 8.0M | 11.9M | 12.9M | 14.2M | ||
| Other Current Liabilities | 9.9M | 11.9M | 12.9M | 27.5M | ||
| Other Liabilities | 18.4M | 21.6M | 24.7M | 37.8M | ||
| Total Liabilities | Long Term Debt | 730.0K | 110.0K | 0.00 | 53.0K | |
| Other Liabilities | 383.0K | 201.0K | 515.0K | 800.0K | ||
| Total Liabilities | 48.4M | 50.7M | 54.0M | 42.5M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 169.5M | 201.7M | 235.4M | 233.0M | ||
| Total Shareholder Equity | 169.5M | 201.7M | 235.4M | 233.0M | ||
| Share Information | Common Shares Outstanding | 41.8M | 58.1M | 69.3M | 79.2M | |
| Addtl. Info. | No data currently available for this section. | |||||
